USFDA issues 'Form 483' with three observations to Lupin US facility
New Delhi, April 18 (IANS) Major drug maker Lupin on Saturday said that the US health regulator has issued a 'Form 483' ...
New Delhi, April 18 (IANS) Major drug maker Lupin on Saturday said that the US health regulator has issued a 'Form 483' ...
Hyderabad: The digitalisation, real-time monitoring and reporting of high-risk Narcotics Drugs and Psychotropic Substanc...
Image for representation purposes only
New Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USF...
Gangtok, April 8 : A team led by Dr. Bhaskar Chakraborty of Sikkim Government College... The post From Himalayan Labs to...
Risks Of Using GLP-1 Drugs Without Prescription: वजन घटाने वालà...
Researchers find snake metabolite that suppresses appetite of obese mice ‘without some of side-effects’ of GLP-1 dru...
Iran War Disrupt Drug Supply Chain: ईरान युद्ध ने बम, गोला-बारूद से ज...
Iran War Disrupt Drug Supply Chain: ईरान युद्ध ने बम, गोला-बारूद से ज...
Iran War Disrupt Drug Supply Chain: ईरान युद्ध ने बम, गोला-बारूद से ज...